The review of the safety data after the first 23 patients is due. The CEO said on a recent webinar that this would occur in early September as the neurologists involved had scheduling difficulties getting together causing a delay. I would anticipate that by now many more than 23 patients have been recruited with all 10 sites now open. I am surprised this has not yet been released. Hopefully, it is imminent
The review of the safety data after the first 23 patients is...
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
73.5¢ |
Change
0.015(2.08%) |
Mkt cap ! $90.94M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 73.5¢ | 71.0¢ | $24.12K | 33.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6497 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 73.0¢ | 6280 | 2 |
View Market Depth
| Last trade - 12.38pm 09/10/2024 (20 minute delay) ? |
| AGN (ASX) Chart |